Gabriel Rubio
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 45
- Co-authors
- Fernando Rodrı́guez de FonsecaFrancisco López‐MuñozCecilio ÁlamoMiguel Ángel Jiménez‐ArrieroG. PonceNicolás Agraı̈tS. VieǐraTomás Palomo
- Journals
- European Psychiatry (16 papers)Frontiers in Psychiatry (11 papers)Adicciones (9 papers)Alcohol and Alcoholism (9 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Gabriel Rubio
240 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Biological Psychiatry 390
- Psychiatry and Mental health 1.1k
- Behavioral Neuroscience 242
- Cellular and Molecular Neuroscience 1.0k
- Applied Psychology 239
Countries citing papers authored by Gabriel Rubio
This map shows the geographic impact of Gabriel Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Rubio more than expected).
Fields of papers citing papers by Gabriel Rubio
This network shows the impact of papers produced by Gabriel Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Rubio. The network helps show where Gabriel Rubio may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Rubio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 4 | |
| 6 | 2021 | 6 | |
| 7 | Antidepressant effect r TMS during pregnancy in a case of Major Depression Resistant to Pharmacological Treatment. | 2021 | 2 |
| 8 | 2020 | 13 | |
| 9 | 2020 | 7 | |
| 10 | 2019 | 34 | |
| 11 | 2018 | 5 | |
| 12 | 2016 | 16 | |
| 13 | 2015 | 6 | |
| 14 | 2014 | 1 | |
| 15 | 2012 | 9 | |
| 16 | 2008 | 96 | |
| 17 | 2006 | 11 | |
| 18 | A propósito de la locura del hidalgo Alonso Quijano en el marco de la medicina española tardorrenacentista | 2006 | 5 |
| 19 | La pérdida de control en la dependencia alcohólica: conceptualización | 1999 | 4 |
| 20 | Evaluation of psychosocial adjustment following cochlear implant in adults | 1996 | 1 |
About Gabriel Rubio
Gabriel Rubio is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology and Neuropsychology and Physiological Psychology, having authored 261 papers that have together received 5.3k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (49 papers), Schizophrenia research and treatment (45 papers), Substance Abuse Treatment and Outcomes (40 papers), Alcohol Consumption and Health Effects (17 papers), Alcoholism and Thiamine Deficiency (16 papers), Treatment of Major Depression (16 papers), Neural and Behavioral Psychology Studies (16 papers) and Mental Health Research Topics (14 papers). The work is most often cited by research in Biological Psychiatry (390 citations), Psychiatry and Mental health (1.1k citations), Behavioral Neuroscience (242 citations), Cellular and Molecular Neuroscience (1.0k citations) and Applied Psychology (239 citations). Gabriel Rubio has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Fernando Rodrı́guez de Fonseca, Francisco López‐Muñoz, Cecilio Álamo, Miguel Ángel Jiménez‐Arriero, G. Ponce, Nicolás Agraı̈t, S. Vieǐra, Tomás Palomo, Roberto Rodríguez–Jiménez and Jorge Manzanares. Their work appears in journals such as European Psychiatry, Frontiers in Psychiatry, Adicciones, Alcohol and Alcoholism and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.